EssilorLuxottica S. A. - Asset Resilience Ratio
EssilorLuxottica S. A. (EL) has an Asset Resilience Ratio of 5.55% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See EssilorLuxottica S. A. working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2001–2024)
This chart shows how EssilorLuxottica S. A.'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see EssilorLuxottica S. A. balance sheet assets.
Liquid Assets Composition Over Time
This chart breaks down EssilorLuxottica S. A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore EL long-term investments to assets to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €3.54 Billion | 5.55% |
| Short-term Investments | €0.00 | 0% |
| Total Liquid Assets | €3.54 Billion | 5.55% |
Asset Resilience Insights
- Limited Liquidity: EssilorLuxottica S. A. maintains only 5.55% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
EssilorLuxottica S. A. Industry Peers by Asset Resilience Ratio
Compare EssilorLuxottica S. A.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Eyebright Medical Technology Beijing Co Ltd
SHG:688050 |
Medical Instruments & Supplies | 1.51% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
Vizionfocus Inc.
TW:4771 |
Medical Instruments & Supplies | 3.24% |
|
Pro-Dex Inc
NASDAQ:PDEX |
Medical Instruments & Supplies | 1.39% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
Mark Dynamics Indonesia Tbk PT
JK:MARK |
Medical Instruments & Supplies | 6.64% |
|
Interojo Inc
KQ:119610 |
Medical Instruments & Supplies | 6.55% |
Annual Asset Resilience Ratio for EssilorLuxottica S. A. (2001–2024)
The table below shows the annual Asset Resilience Ratio data for EssilorLuxottica S. A..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.58% | €375.00 Million ≈ $438.41 Million |
€64.26 Billion ≈ $75.13 Billion |
-0.90pp |
| 2023-12-31 | 1.48% | €896.00 Million ≈ $1.05 Billion |
€60.52 Billion ≈ $70.76 Billion |
-2.14pp |
| 2022-12-31 | 3.62% | €2.19 Billion ≈ $2.56 Billion |
€60.56 Billion ≈ $70.80 Billion |
-4.86pp |
| 2021-12-31 | 8.48% | €5.04 Billion ≈ $5.89 Billion |
€59.41 Billion ≈ $69.46 Billion |
-8.23pp |
| 2020-12-31 | 16.71% | €8.74 Billion ≈ $10.22 Billion |
€52.32 Billion ≈ $61.17 Billion |
+10.09pp |
| 2019-12-31 | 6.62% | €3.48 Billion ≈ $4.07 Billion |
€52.58 Billion ≈ $61.48 Billion |
+5.60pp |
| 2018-12-31 | 1.02% | €496.00 Million ≈ $579.88 Million |
€48.40 Billion ≈ $56.58 Billion |
-3.07pp |
| 2017-12-31 | 4.09% | €412.00 Million ≈ $481.67 Million |
€10.06 Billion ≈ $11.77 Billion |
+3.75pp |
| 2016-12-31 | 0.34% | €45.00 Million ≈ $52.61 Million |
€13.16 Billion ≈ $15.39 Billion |
-0.19pp |
| 2015-12-31 | 0.53% | €64.00 Million ≈ $74.82 Million |
€11.97 Billion ≈ $14.00 Billion |
+0.14pp |
| 2014-12-31 | 0.40% | €43.00 Million ≈ $50.27 Million |
€10.79 Billion ≈ $12.61 Billion |
+0.33pp |
| 2013-12-31 | 0.07% | €5.00 Million ≈ $5.85 Million |
€7.58 Billion ≈ $8.86 Billion |
-0.02pp |
| 2012-12-31 | 0.08% | €5.78 Million ≈ $6.76 Million |
€6.91 Billion ≈ $8.08 Billion |
-0.28pp |
| 2011-12-31 | 0.37% | €22.54 Million ≈ $26.35 Million |
€6.16 Billion ≈ $7.20 Billion |
-0.15pp |
| 2010-12-31 | 0.52% | €26.99 Million ≈ $31.56 Million |
€5.21 Billion ≈ $6.09 Billion |
-1.27pp |
| 2009-12-31 | 1.79% | €74.45 Million ≈ $87.04 Million |
€4.17 Billion ≈ $4.87 Billion |
-0.27pp |
| 2008-12-31 | 2.05% | €83.53 Million ≈ $97.66 Million |
€4.07 Billion ≈ $4.75 Billion |
+0.23pp |
| 2007-12-31 | 1.82% | €63.96 Million ≈ $74.77 Million |
€3.51 Billion ≈ $4.11 Billion |
-0.69pp |
| 2006-12-31 | 2.51% | €78.32 Million ≈ $91.57 Million |
€3.12 Billion ≈ $3.65 Billion |
-15.70pp |
| 2005-12-31 | 18.21% | €551.07 Million ≈ $644.26 Million |
€3.03 Billion ≈ $3.54 Billion |
-3.95pp |
| 2004-12-31 | 22.16% | €572.65 Million ≈ $669.49 Million |
€2.58 Billion ≈ $3.02 Billion |
+1.46pp |
| 2003-12-31 | 20.70% | €516.62 Million ≈ $603.99 Million |
€2.50 Billion ≈ $2.92 Billion |
+11.92pp |
| 2002-12-31 | 8.78% | €189.48 Million ≈ $221.53 Million |
€2.16 Billion ≈ $2.52 Billion |
+7.75pp |
| 2001-12-31 | 1.03% | €22.13 Million ≈ $25.87 Million |
€2.15 Billion ≈ $2.51 Billion |
-- |
About EssilorLuxottica S. A.
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, … Read more